Compumedics (ASX:CMP) is expected to book fiscal first-half sales orders of more than AU$31 million, driven by an over 200% jump in US sales orders year on year, according to a Monday filing with the Australian bourse.
The company forecasts revenue of AU$55 million for the fiscal year ending June 30, 2025, while the outlook of earnings before interest, taxes, depreciation, and amortization of AU$5 million will be weighted to the second half of the year, the filing said.
The medical company said its guidance for the fiscal year will be reviewed after the first half results are finalized.
Its shares rose 2% at market close.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.